Why the FDA Pulled Zantac from the Market
The Zantac crisis began in September 2019, when an independent testing laboratory, Valisure, filed a citizen petition with the FDA reporting unacceptable levels of NDMA in ranitidine products. The FDA initially downplayed the risk, issuing limited recalls and suggesting that NDMA levels were within acceptable limits.
However, further testing revealed that ranitidine's molecular structure is inherently unstable — meaning NDMA levels could increase dramatically over time and under normal storage conditions, and that the drug could generate NDMA inside the body during digestion. By April 2020, the FDA requested that all manufacturers withdraw ranitidine from the market entirely. The decision affected not only the brand-name Zantac but all generic ranitidine products worldwide.
Zantac ranitidine products recalled over cancer risk
Cancer and Health Conditions Linked to Zantac Use
Individuals who took Zantac regularly over extended periods may face an elevated risk of several types of cancer. The cancers most commonly alleged in Zantac litigation include bladder cancer, stomach cancer, esophageal cancer, liver cancer, pancreatic cancer, kidney cancer, and colorectal cancer.
The risk is believed to correlate with duration and frequency of use. Some patients took Zantac daily for years — even decades — to manage chronic heartburn and gastroesophageal reflux disease (GERD). Throughout that entire period, they may have been generating carcinogenic NDMA with every dose. Sanofi, GlaxoSmithKline, Boehringer Ingelheim, and Pfizer are among the manufacturers and marketers named in the litigation.
75+
Years of combined legal experience
$0
Upfront cost to you — we work on contingency
Our attorneys have the trial experience and resources to take on insurance companies and corporate defendants. You pay nothing unless we win your case.
Pursuing a Zantac Cancer Claim with Babin Law
After the federal MDL in the Southern District of Florida was significantly narrowed by a Daubert ruling excluding certain expert testimony, Zantac litigation has shifted to state courts — particularly in Delaware and California — where plaintiffs have achieved more favorable rulings on the admissibility of scientific evidence linking ranitidine to cancer.
Babin Law is actively pursuing Zantac cancer claims in jurisdictions where the litigation remains viable. We work with oncologists and pharmacological experts to build each client's case. If you took Zantac or generic ranitidine regularly and have been diagnosed with cancer, we encourage you to contact us for a free case evaluation. The legal landscape is evolving, and timely action is important to protect your rights.
What to Do If You Took Zantac and Were Diagnosed with Cancer
If you used Zantac (ranitidine) regularly and have been diagnosed with cancer, taking these steps can help you build a strong case and pursue the compensation you may deserve.
Gather Evidence of Your Zantac Use
Collect any evidence documenting your Zantac or ranitidine use. This includes pharmacy records, prescription history, insurance claims, receipts, and even loyalty card purchase data from retailers. Both prescription and over-the-counter use can support a claim.
Obtain Your Complete Cancer Treatment Records
Request all medical records related to your cancer diagnosis, including the initial detection, pathology reports, biopsy results, staging, treatment plans, surgical records, and oncologist notes. A thorough medical record establishes the nature, severity, and timeline of your condition.
Establish a Clear Usage Timeline
Reconstruct when you started using Zantac, how frequently you took it, and for how many years. Daily or near-daily use over an extended period is a significant factor. Your recollection, supported by any available records, helps establish the duration of your NDMA exposure.
Identify the Specific Products and Brands Used
Note whether you used brand-name Zantac, store-brand ranitidine, or generic versions. Different manufacturers and retailers are defendants in the litigation, and identifying the specific products you purchased helps determine which parties are liable in your case.
Contact Babin Law for a Free Case Evaluation
Our attorneys are actively pursuing Zantac cancer claims in state courts where the litigation remains viable. We will evaluate your usage history and cancer diagnosis at no cost and advise you on the strongest jurisdictional strategy for your claim.
What Is Your Zantac Case Worth?
Zantac cancer claim values depend on the type and severity of cancer, the duration of ranitidine use, and the jurisdictional landscape for your particular claim. State court proceedings have produced favorable developments for plaintiffs.
Type and Stage of Cancer
Bladder cancer, stomach cancer, esophageal cancer, liver cancer, and pancreatic cancer are among the conditions most frequently alleged in Zantac litigation. More aggressive cancers requiring extensive treatment and carrying poorer prognoses generally result in higher case valuations.
Duration and Frequency of Zantac Use
Individuals who took Zantac daily for years or decades had the greatest cumulative NDMA generation in their bodies. Documented long-term use significantly strengthens the causation argument and supports higher compensation.
Treatment Costs and Medical Expenses
All medical costs related to your cancer — including diagnosis, surgery, chemotherapy, radiation, immunotherapy, hospital stays, and ongoing monitoring — are recoverable. Projected future treatment costs for recurrence surveillance and follow-up care are also included.
Jurisdictional Strategy
After the federal MDL's Daubert ruling narrowed claims, Zantac litigation has shifted to state courts — particularly Delaware and California — where courts have been more receptive to the scientific evidence. The jurisdiction in which your case is filed can significantly influence its value and likelihood of success.
Impact on Work, Family, and Daily Life
Cancer treatment disrupts every aspect of life. Lost income, inability to work, limitations on daily activities, strain on family relationships, and the emotional burden of a cancer diagnosis are all compensable damages that factor into the total value of your claim.
Zantac litigation is actively proceeding in multiple state courts following developments in the federal MDL. Timely filing in the right jurisdiction is critical to maximizing your claim's potential.
Contact Babin Law for a free Zantac case evaluation. Our attorneys can assess your cancer diagnosis and Zantac usage history to determine the best legal strategy for your situation.
Frequently Asked Questions About Zantac
Get answers to the questions our Columbus attorneys hear most from clients in zantac cases.
Have a question not answered here?
Every case is unique. Our attorneys can answer your specific questions during a free, confidential consultation.
Ask Us DirectlyReady to Discuss Your Case?
Free consultations. No fees unless we win.
